Close

Novavax (NVAX) Announces Receipt of Grant from Bill & Melinda Gates Foundation for RSV F Vaccine Phase 3

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. MSFT


Go back to Novavax (NVAX) Announces Receipt of Grant from Bill & Melinda Gates Foundation for RSV F Vaccine Phase 3
Novavax, Inc. (NASDAQ: NVAX) Delayed: 4.15 --0 (-0%)
Previous Close $4.15    52 Week High $9.23 
Open $4.15    52 Week Low $1.16 
Day High $4.15    P/E N/A 
Day Low $4.15    EPS $-0.30 
Volume 158